Related Experiment Video
Updated: Mar 26, 2026
High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
Published on: March 3, 2015
High Throughput Screening for Colorectal Cancer Specific Compounds
Jingping Xie1, Chunxia Wang, John C Gore2
1VUIIS, Vanderbilt University, Nashville, TN 37232, USA. Jingping.Xie@vanderbilt.edu.
Abstract:
The development of new anti-cancer therapeutic agents is necessary to improve antitumor efficacy and reduce toxicities. Here we report using a systematic anticancer drug screening approach we developed previously, to concurrently screen colon and glioma cancer cell lines for 2000 compounds with known bioactivity and 1920 compounds with unknown activity. The hits specific to each tumor cell line were then selected, and further tested with the same cells transfected with EGFP (Enhanced Green Fluorescent Protein) alone. By comparing the percentage of signal reduction from the same cells transfected with the sensor-conjugated reporter system; hits preferably causing apoptosis were identified. Among the known lead compounds, many cardiac glycosides used as cardiotonic drugs were found to effectively and specifically kill colon cancer cells, while statins (hypolipidemic agents) used as cholesterol lowering drugs were relatively more effective in killing glioma cells.
Insights
New drug screening identified cardiac glycosides effective against colon cancer and statins against glioma. This approach enhances anticancer drug discovery by pinpointing apoptosis-inducing compounds for specific tumor types.
Area of Science:
- Oncology
- Pharmacology
- Biotechnology
Background:
- Developing novel anti-cancer therapeutics is crucial for improving treatment efficacy and minimizing side effects.
- Systematic drug screening offers a powerful method for identifying potential anti-cancer agents.
Purpose of the Study:
- To concurrently screen colon and glioma cancer cell lines for anti-cancer compounds using a previously developed systematic approach.
- To identify drug candidates that specifically induce apoptosis in distinct cancer cell types.
Main Methods:
- Screened 2000 known bioactive and 1920 unknown compounds against colon and glioma cancer cell lines.
- Utilized Enhanced Green Fluorescent Protein (EGFP) transfection and a sensor-conjugated reporter system to quantify apoptosis.
- Selected and validated drug hits based on their ability to reduce EGFP signal, indicating apoptosis induction.
Main Results:
- Cardiac glycosides, typically used as cardiotonic drugs, demonstrated significant efficacy against colon cancer cells.
- Statins, commonly used as hypolipidemic agents, were more effective in targeting glioma cells.
- The screening identified specific drug classes with differential efficacy against distinct cancer types.
Conclusions:
- The systematic screening approach successfully identified known drugs with specific anti-cancer activities against colon and glioma cells.
- Cardiac glycosides and statins represent promising lead compounds for developing targeted therapies for colon and glioma cancers, respectively.
- This study highlights the potential of repurposing existing drugs for novel anti-cancer applications.
